🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Inês Vaz-Luís

Inserm

ORCID: 0000-0002-7194-2260

Also affiliated with Université Paris-Saclay, Institut Gustave Roussy, Centre de recherche en Epidémiologie et Santé des Populations

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer”.

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z
N/A
1.8DataRank · unranked
48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Prediction of Breast Cancer Treatment–Induced Fatigue by Machine Learning Using Genome-Wide Association Data

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa039
N/A
0DataRank · unranked
21 citations

Joseph O. Deasy, Jung Hun Oh, Antonio Di Meglio, Agnès Dumas, Gwenn Menvielle +18 more

Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers

American Society of Clinical Oncology Educational Book(2021)10.1200/edbk_320595
N/A
0DataRank · unranked
24 citations

Prudence A. Francis, Antonio Di Meglio, Vered Stearns, Inês Vaz-Luís

Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis

ESMO Open(2023)10.1016/j.esmoop.2023.102031
N/A
0DataRank · unranked
31 citations

Eva Blondeaux, Marco Bruzzone, Maria Maddalena Latocca, Elene Mariamidze, S. Begijanashvili +16 more